Page last updated: 2024-10-24

busulfan and Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

busulfan has been researched along with Precursor T-Cell Lymphoblastic Leukemia-Lymphoma in 2 studies

Precursor T-Cell Lymphoblastic Leukemia-Lymphoma: A leukemia/lymphoma found predominately in children and young adults and characterized LYMPHADENOPATHY and THYMUS GLAND involvement. It most frequently presents as a lymphoma, but a leukemic progression in the bone marrow is common.

Research Excerpts

ExcerptRelevanceReference
"Busulfan is a cytotoxic agent used in preconditioning for hematopoietic stem cell transplantation."1.46A Significant Influence of Metronidazole on Busulfan Pharmacokinetics: A Case Report of Therapeutic Drug Monitoring. ( Choi, JY; Chung, H; Hong, CR; Hong, KT; Kang, HJ; Lee, S; Park, KD; Shin, HY; Yu, KS, 2017)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chung, H1
Yu, KS1
Hong, KT1
Choi, JY1
Hong, CR1
Kang, HJ1
Park, KD1
Shin, HY1
Lee, S1
Cahu, X1
Labopin, M1
Giebel, S1
Aljurf, M1
Kyrcz-Krzemien, S1
Socié, G1
Eder, M1
Bonifazi, F1
Bunjes, D1
Vigouroux, S1
Michallet, M1
Stelljes, M1
Zuckerman, T1
Finke, J1
Passweg, J1
Yakoub-Agha, I1
Niederwieser, D1
Sucak, G1
Sengeløv, H1
Polge, E1
Nagler, A1
Esteve, J1
Mohty, M1

Other Studies

2 other studies available for busulfan and Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

ArticleYear
A Significant Influence of Metronidazole on Busulfan Pharmacokinetics: A Case Report of Therapeutic Drug Monitoring.
    Therapeutic drug monitoring, 2017, Volume: 39, Issue:3

    Topics: Busulfan; Child, Preschool; Drug Monitoring; Female; Hematopoietic Stem Cell Transplantation; Humans

2017
Impact of conditioning with TBI in adult patients with T-cell ALL who receive a myeloablative allogeneic stem cell transplantation: a report from the acute leukemia working party of EBMT.
    Bone marrow transplantation, 2016, Volume: 51, Issue:3

    Topics: Adult; Busulfan; Cyclophosphamide; Disease-Free Survival; Female; Follow-Up Studies; Hematopoietic S

2016